Skip to main content

Welmate Famotidine 10mg

NDC 73581-108 · YYBA Corp

Generic nameFamotidine 10mg

Dosage formTABLET

RouteORAL

Active ingredient(s)FAMOTIDINE

Strength10 mg/1

Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

73581-108-09 — 90 TABLET in 1 BOTTLE (73581-108-09)

73581-108-10 — 300 TABLET in 1 BOTTLE (73581-108-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72657-112 — Famotidine, 72657-113 — Famotidine, 72657-132 — Famotidine, 72789-331 — Famotidine, 72789-345 — FAMOTIDINE, 72789-427 — Famotidine, 72789-453 — FAMOTIDINE, 72865-214 — Famotidine, 72865-215 — Famotidine, 73097-017 — Famotidine, Calcium carbonate, and Magnesium hydroxide, 73581-109 — Famotidine 20mg, 76162-300 — famotidine, 76420-712 — FAMOTIDINE, 76420-713 — FAMOTIDINE, 76420-891 — Ibuprofen and famotidine, 79903-115 — famotidine, 80005-119 — FAMOTIDINE, 80425-0329 — Famotidine, 80425-0384 — Ibuprofen and famotidine, 80425-0422 — Ibuprofen and famotidine, +401 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels